A Randomized, Open Label, Single-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between DW330SR and DW1030 in Healthy Male Subjects

Trial Profile

A Randomized, Open Label, Single-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between DW330SR and DW1030 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Apr 2015

At a glance

  • Drugs Eperisone (Primary) ; Pelubiprofen (Primary)
  • Indications Back pain; Fever; Osteoarthritis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Daewon Pharmaceutical
  • Most Recent Events

    • 29 Mar 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
    • 07 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top